Clinical Roundup Mayo and Stanford researchers develop first blood test to map tumor “neighborhoods,” improving prediction of therapy response May 08, 2026Vol.52 No.18
Clinical Roundup University of Cincinnati achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy May 08, 2026Vol.52 No.18
Clinical Roundup Cancer metabolism linked to DNA replication errors, UTSW study finds May 08, 2026Vol.52 No.18
Clinical Roundup Inherited long telomeres may drive broad risk for lymphoid cancers, Hopkins-led study finds May 08, 2026Vol.52 No.18
Drugs & Targets FDA permits expanded access for investigational pancreatic cancer drug daraxonrasib May 08, 2026Vol.52 No.18By Claire Marie Porter
Drugs & Targets FDA approves Jakafi XR tablets for myelofibrosis, polycythemia vera, and graft-versus-host disease May 08, 2026Vol.52 No.18
By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panelRansohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists” May 01, 2026Vol.52 No.17By Claire Marie Porter
Regulatory News FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients“Patients are owed another review.” May 01, 2026Vol.52 No.17By Sara Willa Ernst
Benjamin Ebert, Amy Gladfelter, Stephen Liberles, and Pardis Sabeti are among new members of the National Academy of Sciences May 01, 2026Vol.52 No.17
Cancer Policy CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show May 01, 2026Vol.52 No.17By Claire Marie Porter
